XOMA Royalty Corporation - Enterprise Value

The Enterprise Value as of September 2026 (TTM) for XOMA Royalty Corporation (XOMAP) is 534.04M

According to XOMA Royalty Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 534.04M. This represents a change of 19.71% compared to the average of 446.12M of the last 4 quarters.

XOMA Royalty Corporation (XOMAP) Historical Enterprise Value (quarterly & annually)

How has XOMAP Enterprise Value performed in the past?

The mean historical Enterprise Value of XOMA Royalty Corporation over the last ten years is 232.09M. The current 534.04M Enterprise Value has changed 22.91% with respect to the historical average. Over the past ten years (40 quarters), XOMAP's Enterprise Value was at its highest in in the December 2025 quarter at 529.79M. The Enterprise Value was at its lowest in in the December 2016 quarter at 42.95M.

XOMA Royalty Corporation (XOMAP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of XOMA Royalty Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

XOMA Royalty Corporation (XOMAP) Average Enterprise Value

How has XOMAP Enterprise Value performed in the past?

The current Enterprise Value of XOMA Royalty Corporation (XOMAP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

XOMA Royalty Corporation (XOMAP) Enterprise Value vs. Peers

How is XOMAP’s Enterprise Value compared to its peers?

XOMA Royalty Corporation’s Enterprise Value is greater than Tectonic Therapeutic, Inc. (276.06M), greater than Aldeyra The (36.49M), greater than Amarin Corporation plc (138.85M), greater than AC Immune S.A. (194.93M), greater than Lyell Immunopharma, Inc. (226.27M), greater than Genelux Corporation (107.13M), greater than Silence Therapeutics plc (509.04M), greater than Cellectis S.A. (158.82M), greater than Larimar Therapeutics, Inc. (309.31M), greater than Kyverna Therapeutics, Inc. (431.62M),

Build a custom stock screener for XOMA Royalty Corporation (XOMAP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like XOMA Royalty Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

XOMA Royalty Corporation (XOMAP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like XOMA Royalty Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.